Five-Year Summary

 

 

2014

 

2015

 

2016

 

2017

 

2018

 

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

2017 figures restated; figures for 2014 – 2016 as last reported; t = metric tons

1

For definitions of the indicators see Chapter “Alternative Performance Measures Used by the Bayer Group”

2

Group total 2016 including Covestro

3

Employees calculated as full-time equivalents (FTEs)

4

RIR: Number of reportable occupational injuries and illnesses per 200,00 hours worked

5

LoPC = Loss of Primary Containment; number of incidents in which chemicals leak from their primary container, such as pipelines, pumps, tanks or drums, per 200,00 working hours

6

Quotient of total energy consumption and external sales

7

Direct emissions from power plants, waste incinerators and production plants and indirect emissions from external supplies of electricity, steam and refrigeration (according to the market-based method)

Bayer Group

 

 

 

 

 

 

 

 

 

 

Sales

 

41,339

 

46,085

 

34,943

 

35,015

 

39,586

EBITDA1

 

8,315

 

9,573

 

8,801

 

8,563

 

10,266

EBITDA before special items1

 

8,685

 

10,256

 

9,318

 

9,288

 

9,547

EBITDA margin before special items (in %)1

 

21.0

 

22.3

 

26.7

 

26.5

 

24.1

EBIT1

 

5,395

 

6,241

 

5,738

 

5,903

 

3,914

EBIT before special items1

 

5,833

 

7,060

 

6,826

 

7,130

 

6,480

Income before income taxes

 

4,414

 

5,236

 

4,773

 

4,577

 

2,318

Net income (from continuing and discontinued operations)

 

3,426

 

4,110

 

4,531

 

7,336

 

1,695

Earnings per share (from continuing and discontinued operations) (€)1

 

4.14

 

4.97

 

5.44

 

8.29

 

1.80

Core earnings per share (from continuing operations) (€)1

 

5.89

 

6.82

 

6.67

 

6.64

 

5.94

Net cash provided by operating activities (from continuing and discontinued operations)

 

5,810

 

6,890

 

9,089

 

8,134

 

7,917

Net financial debt

 

19,612

 

17,449

 

11,778

 

3,595

 

35,679

Capital expenditures (as per segment table)2

 

2,484

 

2,554

 

2,627

 

2,418

 

2,564

 

 

 

 

 

 

 

 

 

 

 

Bayer AG

 

 

 

 

 

 

 

 

 

 

Total dividend payment

 

1,861

 

2,067

 

2,233

 

2,402

 

2,611

Dividend per share (€)

 

2.25

 

2.50

 

2.70

 

2.80

 

2.80

 

 

 

 

 

 

 

 

 

 

 

Innovation

 

 

 

 

 

 

 

 

 

 

Research and development expenses (€ million)

 

3,537

 

4,274

 

4,405

 

4,504

 

5,246

Ratio of R&D expenses to sales – Pharmaceuticals (%)

 

15.6

 

16.0

 

16.7

 

16.2

 

15.5

Ratio of R&D expenses to sales – Crop Science (%)

 

10.3

 

10.7

 

11.7

 

11.7

 

13.0

Employees in research and development3

 

13,900

 

14,753

 

14,213

 

14,041

 

17,275

 

 

 

 

 

 

 

 

 

 

 

Employees

 

 

 

 

 

 

 

 

 

 

Number of employees3 (Dec. 31)

 

117,400

 

116,600

 

99,592

 

99,820

 

116,998

Personnel expenses (including pension expenses) (€ million)

 

9,693

 

11,176

 

9,459

 

9,528

 

11,548

Proportion of employees with health insurance (%)

 

96

 

96

 

98

 

98

 

98

Fluctuation (voluntary / total) (%)

 

4.8 / 11.4

 

5.0 / 13.9

 

4.8 / 13.2

 

4.8 / 10.4

 

5.4 / 14.4

Hours of vocational and ongoing training per employee

 

18.0

 

20.0

 

23.0

 

23.4

 

17.1

 

 

 

 

 

 

 

 

 

 

 

Safety & Environmental Protection

 

 

 

 

 

 

 

 

 

 

Recordable Incident Rate (RIR) for Bayer employees4

 

0.44

 

0.43

 

0.40

 

0.45

 

0.39

Loss of Primary Containment Incident Rate (LoPC-IR)5

 

0.13

 

0.11

 

0.17

 

0.13

 

0.09

Total energy consumption (terajoules)

 

26,288

 

24,677

 

26,243

 

25,832

 

39,628

Energy efficiency (kWh / €1,000)6

 

246

 

200

 

209

 

205

 

278

Total greenhouse gas emissions (CO2 equivalents in million t)7

 

4.06

 

4.62

 

4.64

 

3.63

 

5.45

Hazardous waste generated (thousand t)

 

377

 

431

 

428

 

485

 

421

Water use (million m³)

 

104

 

110

 

93

 

98

 

124

Compare to Last Year